201 related articles for article (PubMed ID: 25749987)
21. Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.
Fang L; Tang B; Hou D; Meng M; Xiong M; Yang J
BMC Nephrol; 2015 Jun; 16():82. PubMed ID: 26058796
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
23. Weight characteristics of the parathyroid glands in renal hyperparathyroidism.
Debruyne F; Ostyn F; Delaere P
Head Neck; 2000 Aug; 22(5):509-12. PubMed ID: 10897112
[TBL] [Abstract][Full Text] [Related]
24. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
Drüeke TB
Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
[TBL] [Abstract][Full Text] [Related]
25. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
Takahashi H; Komaba H; Takahashi Y; Sawada K; Tatsumi R; Kanai G; Suzuki H; Kakuta T; Fukagawa M
J Clin Endocrinol Metab; 2014 Apr; 99(4):E652-8. PubMed ID: 24476081
[TBL] [Abstract][Full Text] [Related]
26. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.
Nakamura M; Tanaka K; Marui Y; Tomikawa S
Ther Apher Dial; 2013 Oct; 17(5):551-6. PubMed ID: 24107283
[TBL] [Abstract][Full Text] [Related]
28. Atypical spindle cell lesions in secondary parathyroid hyperplasia.
Masuda A; Nishikawa T; Yamamoto T; Aiba M; Kobayashi M
Histopathology; 2008 Feb; 52(3):402-4. PubMed ID: 18269591
[No Abstract] [Full Text] [Related]
29. Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Ichii M; Ishimura E; Okuno S; Chou H; Kato Y; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
Nephron Clin Pract; 2010; 115(3):c195-202. PubMed ID: 20413997
[TBL] [Abstract][Full Text] [Related]
30. De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism.
Gogusev J; Duchambon P; Stoermann-Chopard C; Giovannini M; Sarfati E; Drüeke TB
Nephrol Dial Transplant; 1996 Nov; 11(11):2155-62. PubMed ID: 8941573
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.
Martins P; Schmitt F; Almeida H; Frazão JM
Nephrol Dial Transplant; 2008 Sep; 23(9):2889-94. PubMed ID: 18398016
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure.
Martín-Salvago M; Villar-Rodríguez JL; Palma-Alvarez A; Beato-Moreno A; Galera-Davidson H
Endocr Pathol; 2003; 14(1):61-70. PubMed ID: 12746564
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
Galitzer H; Ben-Dov IZ; Silver J; Naveh-Many T
Kidney Int; 2010 Feb; 77(3):211-8. PubMed ID: 20016468
[TBL] [Abstract][Full Text] [Related]
35. Regression of parathyroid gland swelling by treatment with cinacalcet.
Terawaki H; Nakano H; Takeguchi F; Hasegawa T; Nakayama M; Okazaki M; Hosoya T
Nephrol Dial Transplant; 2009 Feb; 24(2):690-1; author reply 691-2. PubMed ID: 18987257
[No Abstract] [Full Text] [Related]
36. Relationship between the weight of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
Kakuta T; Tanaka R; Kanai G; Miyamoto Y; Inagaki M; Suzuki H; Fukagawa M; Saito A
Ther Apher Dial; 2008 Oct; 12(5):385-90. PubMed ID: 18937722
[TBL] [Abstract][Full Text] [Related]
37. FGF23 fails to inhibit uremic parathyroid glands.
Canalejo R; Canalejo A; Martinez-Moreno JM; Rodriguez-Ortiz ME; Estepa JC; Mendoza FJ; Munoz-Castaneda JR; Shalhoub V; Almaden Y; Rodriguez M
J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
[TBL] [Abstract][Full Text] [Related]
39. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
Korkor AB
N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
[TBL] [Abstract][Full Text] [Related]
40. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
